News
![Kenji Yasukawa](https://pharmaphorum.com/wp-content/uploads/2018/08/Kenji-Yasukawa.jpg)
Astellas buys eye gene therapy biotech Quethera for $109m
Japanese Astellas Pharma has bought privately-owned biotech Quethera for $109 million, gaining access to its gene therapy focused on developing novel treatments for glaucoma and eye disorde